期刊文献+

脓毒性休克患者的麻醉处理 被引量:4

下载PDF
导出
出处 《临床麻醉学杂志》 CAS CSCD 2008年第11期989-991,共3页 Journal of Clinical Anesthesiology
  • 相关文献

参考文献15

  • 1何征宇,皋源,王祥瑞,杭燕南.早期目标导向治疗在感染性休克中应用的临床探讨[J].中国危重病急救医学,2007,19(1):14-16. 被引量:32
  • 2Bridges EJ,Dukes S. Cardiovascular aspects of septic shock: pathophysiology, monitoring, and treatment. Crit Care Nurse,2005,25: 14-24.
  • 3LaRosa SP, Opal SM, Utterback B, et al. Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei. Int J Infect Dis, 2006,10;25-31.
  • 4Andrejaitiene J. The diagnostic value of procalcitonin in severe sepsis. Medicina (Kaunas), 2006,42:69-78.
  • 5Levy MM, Pronovost PJ, Dellinger RP, et al. Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med, 2004,32 ( 11 Suppl) : 595-597.
  • 6Rivers E, Nguyen B, Havstad S, et al. Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med, 2001, 345:1368-1377.
  • 7Nguyen HB,Corbett SW, Steele R, et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med, 2007, 35: 1105-1112.
  • 8Katsaragakis,S, Kapralou A, Theodorou D,et al. Refractory septic shoek effieaey and safety of very high doses of norepinepbrine. Methods Find Exp Clin Pharmacol, 2006,28: 307-313.
  • 9侯立朝,熊利泽,陈绍洋,计根林,王雅丽,陈敏.去甲肾上腺素对感染性休克患者肾脏功能的影响[J].临床麻醉学杂志,2007,23(2):144-146. 被引量:4
  • 10Macarthur RD, Miller M, Albertson T, et al. Adequacy of early empiric aptibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis, 2004,38:284-288.

二级参考文献15

  • 1邱海波,杨毅,刘松桥.《2004严重感染和感染性休克治疗指南》系列讲座(2) 严重感染和感染性休克的容量复苏和血管活性药物应用[J].中国危重病急救医学,2004,16(8):451-453. 被引量:111
  • 2Hurford WE,主编:危重症监测治疗手册.第3版.王俊科,郑斯聚,盛卓人,主译.沈阳:辽宁科学技术出版社,2001.124.
  • 3Rivers E,Nguyen B,Havstad S,et al.Early goal directed therapy in the treatment of severe sepsis and septic shock[J].N Engl J Med,2001,345(19):1368-1377.
  • 4Dellinger R P,Carlet J M,Masur H,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J].Crit Care Med,2004,32(3):858-873.
  • 5Levy M M,Fink M P,Marshall J C,et al.2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference[J].Crit Care Med,2003,31(4):1250-1256.
  • 6Task force of the American college of critical care medicine,society of critical care medicine.Practice parameters for hemodynamic support of sepsis in adult patients in sepsis[J].Crit Care Med,1999,27(3):639-660.
  • 7Marshall J C,Cook D J,Christou N V,et al.Multiple organ dysfunction score:a reliable descriptor of a complex clinical outcome[J].Crit Care Med,1995,23(10):1638-1652.
  • 8Fitch S J,Gossage J R.Optimal management of septic shock,rapid recognition and institution of therapy are crucial[J].Postgrad Med,2002,111(3):53-56,59-60,63-64.
  • 9Ruokonen E,Parviainen I,Uusaro A.Treatment of impaired perfusion in septic shock[J].Ann Med,2002,34(7-8):590-597.
  • 10Patel B M,Chittock D R,Russell J A,et al.Beneficial effects of short-term vasopressin infusion during severe septic shock[J].Anesthesiology,2002,96(3):576-582.

共引文献34

同被引文献25

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部